X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5379) 5379
Newsletter (326) 326
Publication (303) 303
Book Review (49) 49
Book Chapter (36) 36
Magazine Article (20) 20
Newspaper Article (11) 11
Book / eBook (7) 7
Conference Proceeding (7) 7
Dissertation (7) 7
Web Resource (2) 2
Data Set (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4217) 4217
dermatomyositis (3158) 3158
female (2495) 2495
male (2028) 2028
middle aged (1638) 1638
polymyositis (1617) 1617
dermatomyositis - drug therapy (1541) 1541
adult (1509) 1509
index medicus (1403) 1403
rheumatology (1370) 1370
dermatomyositis - complications (1094) 1094
aged (941) 941
dermatomyositis - diagnosis (896) 896
child (820) 820
myositis (691) 691
treatment outcome (668) 668
adolescent (654) 654
immunosuppressive agents - therapeutic use (584) 584
dermatomyositis - pathology (557) 557
dermatomyositis - therapy (549) 549
juvenile dermatomyositis (547) 547
dermatology (499) 499
prognosis (484) 484
therapy (475) 475
care and treatment (434) 434
research (421) 421
dermatomyositis - immunology (413) 413
biopsy (407) 407
child, preschool (401) 401
idiopathic inflammatory myopathies (399) 399
diagnosis, differential (388) 388
medicine, general & internal (388) 388
diagnosis (380) 380
autoantibodies (372) 372
retrospective studies (364) 364
disease (349) 349
prednisone - therapeutic use (344) 344
myositis - drug therapy (292) 292
adrenal cortex hormones - therapeutic use (291) 291
drug therapy, combination (288) 288
follow-up studies (280) 280
medicine & public health (277) 277
arthritis (276) 276
glucocorticoids - therapeutic use (275) 275
interstitial lung-disease (269) 269
risk factors (268) 268
myositis - diagnosis (267) 267
dermatomyositis - physiopathology (263) 263
polymyositis - drug therapy (258) 258
medical research (249) 249
inclusion-body myositis (248) 248
prednisolone - therapeutic use (245) 245
immunoglobulins, intravenous - therapeutic use (243) 243
immunology (243) 243
patients (240) 240
rheumatoid-arthritis (231) 231
cancer (230) 230
children (230) 230
antibodies (224) 224
clinical neurology (224) 224
lung diseases (224) 224
dermatomyositis - etiology (220) 220
methotrexate - therapeutic use (219) 219
pediatrics (219) 219
inflammatory myopathies (217) 217
corticosteroids (216) 216
anti-inflammatory agents - therapeutic use (213) 213
autoimmune diseases (213) 213
medicine, experimental (211) 211
myositis - immunology (210) 210
systemic-lupus-erythematosus (202) 202
health aspects (200) 200
immunoglobulins (199) 199
interstitial lung disease (199) 199
muscle, skeletal - pathology (199) 199
time factors (197) 197
abridged index medicus (196) 196
drug therapy (194) 194
skin (194) 194
lung diseases, interstitial - drug therapy (188) 188
creatine kinase - blood (185) 185
inflammation (184) 184
methotrexate (181) 181
severity of illness index (178) 178
autoimmunity (177) 177
myositis - therapy (176) 176
polymyositis - complications (175) 175
dermatomyositis - blood (167) 167
electromyography (167) 167
aged, 80 and over (166) 166
rituximab (163) 163
autoantibodies - blood (162) 162
skin - pathology (162) 162
amyopathic dermatomyositis (160) 160
neurosciences (159) 159
pneumonia (158) 158
disease progression (156) 156
magnetic resonance imaging (155) 155
young adult (155) 155
scleroderma (152) 152
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4793) 4793
French (237) 237
German (236) 236
Japanese (155) 155
Spanish (85) 85
Russian (59) 59
Polish (41) 41
Italian (30) 30
Hungarian (24) 24
Portuguese (24) 24
Korean (23) 23
Chinese (22) 22
Dutch (17) 17
Czech (9) 9
Croatian (6) 6
Serbian (6) 6
Norwegian (4) 4
Romanian (4) 4
Danish (2) 2
Finnish (2) 2
Hebrew (2) 2
Slovak (2) 2
Swedish (2) 2
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1963, American lecture series, publication no. 520. A monograph in the Bannerstone Division of American lectures in living chemistry, 161
Book
Autoimmunity Reviews, ISSN 1568-9972, 2011, Volume 11, Issue 1, pp. 6 - 13
Journal Article
1980, ISBN 0632003731, x, 194
Book
Journal of Bone and Mineral Research, ISSN 0884-0431, 09/2015, Volume 30, Issue 9, pp. 1667 - 1675
Vertebral fractures are an important yet underrecognized manifestation of osteoporosis in children with chronic, glucocorticoid-treated illnesses. Our goal was... 
GLUCOCORTICOIDS | BONE DENSITY | VERTEBRAL FRACTURES | RHEUMATIC DISORDERS | ADOLESCENTS | CHILDREN | rheumatic disorders | glucocorticoids | adolescents | children | vertebral fractures | bone density | INDUCED OSTEOPOROSIS | SYSTEMIC-LUPUS-ERYTHEMATOSUS | BONE HEALTH | JUVENILE IDIOPATHIC ARTHRITIS | DISEASE-ACTIVITY | THERAPY | GROWTH | ENDOCRINOLOGY & METABOLISM | COMPRESSION FRACTURES | Glucocorticoids - therapeutic use | Lupus Erythematosus, Systemic - complications | Rheumatic Diseases - drug therapy | Scleroderma, Localized - complications | Humans | Male | Osteoporosis - drug therapy | Dermatomyositis - complications | Arthritis, Juvenile - drug therapy | Incidence | Systemic Vasculitis - complications | Dermatomyositis - drug therapy | Scleroderma, Systemic - complications | Lupus Erythematosus, Systemic - drug therapy | Female | Child | Glucocorticoids - adverse effects | Spinal Fractures - diagnosis | Scleroderma, Localized - drug therapy | Bone Density | Risk Factors | Proportional Hazards Models | Spinal Fractures - epidemiology | Systemic Vasculitis - drug therapy | Spinal Fractures - chemically induced | Adolescent | Arthritis, Juvenile - complications | Rheumatic Diseases - complications | Scleroderma, Systemic - drug therapy | Cohort Studies | Pediatrics | Fractures | Corticosteroids | Bones | Children | Health aspects | Density | Risk factors | Steroids
Journal Article
British Journal of Dermatology, ISSN 0007-0963, 09/2019, Volume 181, Issue 3, pp. e73 - e73
PD‐1 inhibitors are a relatively new type of drug that are used to treat patients with metastatic (widespread) cancers. Examples include drugs called... 
Lupus | Skin | Hydroxychloroquine | Dermatomyositis | Thyroid diseases | Connective tissue diseases | Tumor necrosis factor-α | Immunosuppressive agents | Metastases | Connective tissues | Pembrolizumab | Vitiligo | Side effects | Infliximab | Cutaneous Lupus Erythematosus | Eczema | Monoclonal antibodies | Skin diseases | Colitis | Autoimmune diseases | Thyroid | Immune system
Journal Article
Nature Reviews Rheumatology, ISSN 1759-4790, 11/2014, Volume 10, Issue 11, pp. 662 - 670
For patients that present with musculoskeletal symptoms, diagnostic procedures carried out by physicians and rheumatologists are primarily aimed at confirming... 
ADULT PATIENTS | DERMATOMYOSITIS | CANCER-PATIENTS | SERONEGATIVE SYMMETRICAL SYNOVITIS | POLYARTHRITIS SYNDROME | PITTING EDEMA SYNDROME | HYPERTROPHIC PULMONARY OSTEOARTHROPATHY | RHEUMATOLOGY | PALMAR FASCIITIS | CARCINOMA | ENDOTHELIAL GROWTH-FACTOR | Myositis - etiology | Humans | Arthritis - diagnosis | Paraneoplastic Syndromes - diagnosis | Musculoskeletal Diseases - diagnosis | Rheumatic Diseases - etiology | Myositis - therapy | Neoplasms - complications | Osteomalacia - diagnosis | Synovitis - therapy | Osteomalacia - etiology | Osteoarthropathy, Secondary Hypertrophic - diagnosis | Synovitis - etiology | Arthritis - etiology | Fasciitis - diagnosis | Osteomalacia - therapy | Synovitis - diagnosis | Musculoskeletal Diseases - therapy | Edema - therapy | Rheumatic Diseases - therapy | Paraneoplastic Syndromes - therapy | Musculoskeletal Diseases - etiology | Fasciitis - therapy | Myositis - diagnosis | Paraneoplastic Syndromes - etiology | Rheumatic Diseases - diagnosis | Syndrome | Edema - diagnosis | Edema - etiology | Fasciitis - etiology | Osteoarthropathy, Secondary Hypertrophic - etiology | Arthritis - therapy | Osteoarthropathy, Secondary Hypertrophic - therapy | Complications and side effects | Rheumatic diseases | Development and progression | Genetic aspects | Properties | Growth factors | Tumors
Journal Article
Journal Article
Clinical and Experimental Rheumatology, ISSN 0392-856X, 05/2018, Volume 36, Issue 3, pp. 0490 - 0493
Objective. Guidelines for preventing Pneumocystis pneumonia (PCP) in HIV patients are based on CD4 below 200/mm(3). Such cut-off value is suggested to guide... 
T-lymphocytes | CD4-count | Autoimmune and inflammatory diseases | Prophylaxis | Pneumocystis pneumonia | RISK-FACTORS | JIROVECII PNEUMONIA | RHEUMATOLOGY | prophylaxis | autoimmune and inflammatory diseases | CARE | Pneumonia, Pneumocystis - etiology | Humans | Middle Aged | Hepatitis, Autoimmune - drug therapy | Pneumonia, Pneumocystis - prevention & control | Male | Organ Transplantation | Arthritis, Rheumatoid - complications | Cryoglobulinemia - complications | Dermatomyositis - complications | Lymphopenia - etiology | CD4-Positive T-Lymphocytes - immunology | Neoplasms - complications | Neoplasms - therapy | Dermatomyositis - immunology | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - complications | Arthritis, Rheumatoid - drug therapy | Dermatomyositis - drug therapy | Aged, 80 and over | Adult | Female | Retrospective Studies | Autoimmune Diseases - drug therapy | Giant Cell Arteritis - immunology | Cryoglobulinemia - drug therapy | Autoimmune Diseases - complications | Autoimmune Diseases - immunology | Giant Cell Arteritis - complications | Giant Cell Arteritis - drug therapy | Pneumonia, Pneumocystis - immunology | Hepatitis, Autoimmune - immunology | CD4 Lymphocyte Count | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - drug therapy | Cryoglobulinemia - immunology | Hepatitis, Autoimmune - complications | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - immunology | Lymphopenia - drug therapy | Neoplasms - immunology | HIV Infections - complications | HIV Infections - therapy | Immunosuppressive Agents - adverse effects | Aged | Disease Management | Lymphopenia - immunology | Immunocompromised Host | Arthritis, Rheumatoid - immunology | Practice Guidelines as Topic
Journal Article
Clinical Rheumatology, ISSN 0770-3198, 2015, Volume 34, Issue 3, pp. 609 - 612
Journal Article
Clinical Rheumatology, ISSN 0770-3198, 4/2014, Volume 33, Issue 4, pp. 577 - 586
The aims of this paper are to report hepatitis B virus reactivation in 12 patients with rheumatic disease undergoing immunosuppressive therapy and to evaluate... 
Steroid | Tumor necrosis factor-alpha-blocking agent | Disease-modifying anti-rheumatic drugs | Medicine & Public Health | Rheumatology | Hepatitis B | Rheumatic disease | STEROID TREATMENT | VIRUS REACTIVATION | ALPHA | ANTIBODY | B SURFACE-ANTIGEN | ANKYLOSING-SPONDYLITIS | RHEUMATOLOGY | CARRIERS | ARTHRITIS PATIENTS | NEGATIVE PATIENT | INFLIXIMAB | Azathioprine - therapeutic use | Lupus Erythematosus, Systemic - complications | Rheumatic Diseases - drug therapy | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Spondylitis, Ankylosing - complications | Arthritis, Rheumatoid - complications | Dermatomyositis - complications | Young Adult | Arthritis, Rheumatoid - drug therapy | Dermatomyositis - drug therapy | Lupus Erythematosus, Cutaneous - drug therapy | Lupus Erythematosus, Systemic - drug therapy | Adult | Female | Virus Activation | Antiviral Agents - therapeutic use | Spondylitis, Ankylosing - drug therapy | Hepatitis B virus - physiology | Hepatitis B, Chronic - complications | Hepatitis B, Chronic - drug therapy | Adolescent | Rheumatic Diseases - complications | Aged | Lupus Erythematosus, Cutaneous - complications | Prednisone - therapeutic use | Cohort Studies | Hepatitis | Antiviral agents | Medical colleges | Care and treatment | Corticosteroids | Antirheumatic agents | Immunotherapy | Case Based Review
Journal Article
British Journal of Dermatology, ISSN 0007-0963, 12/2018, Volume 179, Issue 6, pp. 1233 - 1234
Linked Articles:   Thompson et al. Br J Dermatol 2018; 179 :1256–1262 . Callander et al. Br J Dermatol 2018; 179 :1248–1255. 
DISEASE-ACTIVITY | DERMATOLOGY | Dermatomyositis
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2016, Volume 6, Issue 1, p. 39474
Th17 and TfH cells are thought to promote tissue inflammation and autoantibody production, respectively, in autoimmune diseases including rheumatoid arthritis... 
B-CELLS | INTERLEUKIN-17 | MULTIDISCIPLINARY SCIENCES | FREQUENCY | SUBSETS | ANTIBODY | DIFFERENTIATION | EXPRESSION | T-CELLS | IL-21 | TH17 CELLS | Biomarkers - metabolism | Receptors, CXCR5 - metabolism | Monocytes - cytology | Humans | Middle Aged | Male